biomarker and surrogate targets for successful therapy in polycythemia vera (pv)
Published 9 years ago • 130 plays • Length 18:19Download video MP4
Download video MP3
Similar videos
-
18:19
biomarker and surrogate targets for successful therapy in polycythemia vera (pv)
-
5:47
surrogate endpoint biomarkers in research
-
2:20
biomarkers and surrogate endpoints in drug development
-
2:50
ace immunoid for biomarker discovery
-
1:12
dr. battiste on biomarkers in glioblastoma
-
1:56
dr. paul stewart - metabolomics society
-
2:54
biomarker testing myths
-
24:22
do we have reliable biomarkers to guide use of immunotherapy agents?
-
1:38
optimizing biomarker testing to steer treatment decisions
-
15:37
tusy0205 - what are possible biomarkers for cure-related interventions?
-
6:11
targeted therapy for advanced solid tumors based on molecular profiles: early results from mypathway
-
1:18:56
ac20 - different modalities for profiling
-
1:35
clinician-scientists discover new biomarkers to predict heart failure after a heart attack
-
4:59
a novel biomarker for paediatic tumours
-
5:22
can we trust today's biomarkers ?
-
1:22
the current and future uses of the immunoscore
-
17:40
novel biomarkers of cardiovascular risk: an unbiased proteomic approach | peter ganz
-
17:30
immunotherapy in lung cancer: panacea vs. reality?
-
7:11
tumor immunogenicity biomarkers: the potential of immunoscore ic® (cd8/pdl1) in drug development